Audere Capital
Venture capitalActively deployingRidgefield · Series A–Late Stage · 20 people tracked
Investment thesis
Audere focuses on advanced technology, positioning itself at the intersection of strategy, intelligence, and investment. The firm collaborates with governments, corporations, and industry leaders to accelerate breakthrough technologies that it views as central to economic strength and global security. Its emphasis on defense and security-relevant deep technology suggests a focus on capabilities with national and geopolitical significance.
Source: firm website, verified Aug 3, 2026.
Team · 20 people
from the firm's websiteFrequently asked questions
- What stage does Audere Capital invest at?
- Audere Capital invests at the Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Audere Capital focus on?
- Audere Capital focuses on AI & Machine Learning, Deep Tech, Defense Tech, Healthtech, New Materials, Robotics.
- Where is Audere Capital located?
- Audere Capital is headquartered in Ridgefield, US.
Images
Similar investors
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Blindspot Ventures is an infrastructure-focused technology investment fund that backs founders building foundational platforms, systems, and technologies for critical industries.
Geodesic Capital is a venture firm that invests in multi-stage technology companies and helps them expand into Asian markets, starting with Japan, through strategic guidance and market access.
Quad Ventures is a Korean venture capital firm that identifies founders driving lifestyle and industry change and invests in the technologies enabling them, backing early-stage startups across advanced technology sectors.
LIFTT is a venture capital holding company focused on deep tech technologies, using an operational, multi-vertical approach aimed at generating impact. It works to transform scientific research into high-impact companies, accelerating the path from lab to market.



